Yu Jung Kim Selected Research

Yu Jung Kim Research Topics

Disease

67	Neoplasms (Cancer) 04/2022 - 03/2008
27	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022 - 01/2009
18	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2008
15	Breast Neoplasms (Breast Cancer) 10/2020 - 06/2011
13	Neoplasm Metastasis (Metastasis) 10/2018 - 03/2008
12	Lung Neoplasms (Lung Cancer) 01/2021 - 12/2008
10	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2011
9	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 10/2005
9	Glioma (Gliomas) 04/2022 - 01/2011
7	Infections 10/2021 - 04/2009
6	Carcinoma (Carcinomatosis) 12/2020 - 03/2011
4	Chronic Disease (Chronic Diseases) 11/2021 - 12/2018
4	Death (Near-Death Experience) 10/2021 - 03/2014
4	Pain (Aches) 09/2020 - 04/2016
4	Astrocytoma (Pilocytic Astrocytoma) 10/2019 - 01/2011
3	Dyspnea (Shortness of Breath) 04/2022 - 03/2015
3	Brain Neoplasms (Brain Tumor) 04/2022 - 02/2018
3	Lymphoma (Lymphomas) 12/2021 - 11/2019
3	Pneumonia (Pneumonitis) 11/2018 - 12/2008
2	Vomiting 04/2022 - 01/2021
2	Diarrhea 04/2022 - 07/2018
2	Constipation 04/2022 - 03/2015
2	Nausea 04/2022 - 01/2021
2	Anorexia 04/2022 - 07/2018
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 07/2017
2	Melanoma (Melanoma, Malignant) 01/2021 - 11/2015
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021 - 07/2017
2	Human Influenza (Influenza) 11/2020 - 11/2020
2	Oligodendroglioma 10/2019 - 10/2019
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2019 - 10/2017
2	Alcoholism (Alcohol Abuse) 01/2019 - 04/2016
2	Adenocarcinoma 01/2019 - 08/2017
2	Clonorchiasis 08/2018 - 05/2017
2	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 12/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2017 - 07/2015

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 10/2021 - 03/2008
11	Temozolomide (Temodar)FDA LinkGeneric 04/2022 - 01/2011
10	Biomarkers (Surrogate Marker)IBA 10/2022 - 12/2011
9	Immune Checkpoint InhibitorsIBA 10/2022 - 11/2018
8	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2008
7	ErbB Receptors (EGF Receptor)IBA 01/2022 - 07/2009
7	PlatinumIBA 10/2018 - 03/2011
6	Trastuzumab (Herceptin)FDA Link 12/2019 - 01/2008
5	Tyrosine Kinase InhibitorsIBA 02/2021 - 07/2009
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 07/2014
5	Phenobarbital (Luminal)FDA Link 11/2018 - 01/2017
4	Anaplastic Lymphoma KinaseIBA 01/2022 - 10/2017
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2021 - 10/2013
4	Gemcitabine FDA Link 01/2021 - 09/2014
4	Opioid Analgesics (Opioids)IBA 09/2020 - 04/2016
4	Pemetrexed (MTA)FDA Link 11/2019 - 01/2009
4	taxaneIBA 10/2018 - 01/2012
4	human ERBB2 proteinIBA 06/2018 - 07/2012
4	AntigensIBA 07/2017 - 01/2009
3	EnzymesIBA 10/2021 - 01/2015
3	Indicators and Reagents (Reagents)IBA 02/2021 - 10/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 03/2011
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 02/2013
3	Vincristine (Oncovin)FDA LinkGeneric 01/2021 - 10/2019
3	Progesterone Receptors (Progesterone Receptor)IBA 11/2018 - 06/2018
3	Docetaxel (Taxotere)FDA Link 01/2018 - 11/2014
3	Thymidylate SynthaseIBA 08/2017 - 12/2011
3	Carcinoembryonic AntigenIBA 07/2017 - 01/2009
3	Fluorouracil (Carac)FDA LinkGeneric 04/2014 - 02/2013
2	Cetuximab (Erbitux)FDA Link 11/2022 - 12/2021
2	Inosine Triphosphate (ITP)IBA 01/2022 - 07/2017
2	Levetiracetam (Keppra)FDA LinkGeneric 01/2022 - 09/2015
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 12/2021 - 10/2015
2	pazopanib FDA Link 10/2021 - 01/2019
2	B7-H1 AntigenIBA 02/2021 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2020
2	Phosphotransferases (Kinase)IBA 01/2021 - 11/2019
2	Peptides (Polypeptides)IBA 10/2020 - 01/2017
2	AlpelisibIBA 09/2020 - 01/2020
2	erucylphosphocholineIBA 06/2020 - 01/2018
2	Procarbazine (Matulane)FDA Link 10/2019 - 10/2019
2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2019 - 10/2019
2	Lomustine (CCNU)FDA Link 10/2019 - 10/2019
2	Morphine (MS Contin)FDA LinkGeneric 01/2019 - 04/2016
2	Estrogen ReceptorsIBA 11/2018 - 06/2018
2	Pharmaceutical PreparationsIBA 07/2018 - 01/2015
2	Hormones (Hormone)IBA 10/2017 - 01/2017
2	p21-Activated KinasesIBA 08/2017 - 07/2015
2	Tumor Biomarkers (Tumor Markers)IBA 07/2017 - 01/2009
2	CarbohydratesIBA 07/2017 - 01/2009

Therapy/Procedure

60	Drug Therapy (Chemotherapy) 04/2022 - 10/2005
29	Therapeutics 01/2022 - 01/2011
18	Palliative Care (Palliative Therapy) 04/2022 - 08/2009
15	Radiotherapy 04/2022 - 01/2011
10	Adjuvant Chemotherapy 01/2022 - 03/2008
7	Chemoradiotherapy 04/2022 - 04/2014
6	Combination Drug Therapy (Combination Chemotherapy) 10/2019 - 09/2010
3	Terminal Care (Care, Terminal) 01/2022 - 01/2019
3	Salvage Therapy 10/2015 - 07/2014
3	Neoadjuvant Therapy 01/2015 - 07/2011
2	Immunotherapy 04/2022 - 09/2017
2	Metastasectomy 12/2019 - 06/2011
2	Gastrectomy 12/2019 - 06/2011
2	Critical Care (Surgical Intensive Care) 01/2019 - 03/2014
2	Adjuvant Radiotherapy 10/2018 - 06/2017